Biotech
How RFK, China and leadership woes became a $4b storm for this Australian corporate giant
CSL’s share price has now halved in 18 months, shredding more than $70 billion of shareholder wealth after the latest writedowns and operational struggles.
- Colin Kruger
Latest
Boss of $83b giant CSL exits abruptly
Australian pharmaceuticals heavyweight CSL says its chief executive Paul McKenzie is leaving the company with immediate effect.
- Clancy Yeates
The married scientists torn apart by a COVID bioweapon theory
In 2020, a Chinese virologist fled to the US, aided by allies of Donald Trump who sought to promote her unproven theories about the origins of COVID-19. Her husband still can’t find her.
- Katie J.M. Baker
I did nothing wrong, Theranos founder Elizabeth Holmes claims from prison
Holmes is two years into an 11-year prison sentence for defrauding investors, including Rupert Murdoch and Silicon Valley tycoon Larry Ellison.
- James Titcomb
The radical Australian experiments forcing the world to confront the ethics of life
From pig wings and lab-grown meat to mini-brains that make music, Perth has become a hub where art and science collide, raising profound ethical questions about what it means to be alive.
- Carla Hildebrandt
- Analysis
- Trump's White House
Trump’s tariffs and anti-vaxxer clash with Australia’s $130b health giant
CSL is battling the US president’s threat against big pharma and the vaccine scepticism of his health tsar, but that’s not why its shares plunged on Tuesday.
- Colin Kruger
This neuroscientist wants you to live forever. Here’s how
What if you could cryonically freeze your brain and be revived in the future? It’s not so far-fetched.
- Cassidy Knowlton
- Sponsored
- Bulls N' Bears
Strategic CEO hire to drive NeuroScientific stem cell therapy release
NeuroScientific Biopharmaceuticals has made a second heavy-hitting appointment, with Melbourne-based exec Nathan Smith bringing his stem cell therapy nous as CEO.
- James Pearson
‘Collaborating with nature’: Designer debuts living dress in Paris runway show
Dutch designer Iris van Herpen harnessed bioluminescent algae to create a living dress. How long will the algae ultimately live after the runway? “No one knows!”
- Vanessa Friedman
- Updated
- Wall Street
This mysterious company has never sold a single product. Its founder is now worth $51 billion
A company that aims to treat neurological conditions such as ADHD and autism has made a dizzying share price surge without a single sale. It has made its founder very rich.
- Angel Adegbesan and Dylan Sloan